Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?

Carlo Foppiano Palacios; Vaidehi Chowdhary; Ritche Hao; Abhijeet Danve; Maricar Malinis

doi:10.1371/journal.pone.0306337

Loading metrics

Open Access

Peer-reviewed

Research Article

Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?

Carlo Foppiano Palacios ,

Roles Data curation, Formal analysis, Methodology, Writing – original draft

* E-mail: foppianopalacios-car@cooperhealth.edu (CFP); Maricar.malinis@yale.edu (MM)

Affiliation Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

https://orcid.org/0000-0002-2698-981X

⨯
Vaidehi Chowdhary,

Roles Conceptualization, Writing – review & editing

Affiliation Section of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Ritche Hao,

Roles Data curation, Writing – review & editing

Affiliation Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Abhijeet Danve,

Roles Conceptualization, Writing – review & editing

Affiliation Section of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Maricar Malinis

Roles Conceptualization, Methodology, Supervision, Writing – review & editing

* E-mail: foppianopalacios-car@cooperhealth.edu (CFP); Maricar.malinis@yale.edu (MM)

Affiliations Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America, Department of Surgery (Transplant), Yale University School of Medicine, New Haven, Connecticut, United States of America

https://orcid.org/0000-0002-5720-9994

⨯

Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?

Carlo Foppiano Palacios,
Vaidehi Chowdhary,
Ritche Hao,
Abhijeet Danve,
Maricar Malinis

Published: July 3, 2024
https://doi.org/10.1371/journal.pone.0306337

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Rheumatology
Is the Subject Area "Rheumatology" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.
Electronic medical records
Is the Subject Area "Electronic medical records" applicable to this article?

Thanks for your feedback.
Language
Is the Subject Area "Language" applicable to this article?

Thanks for your feedback.
Screening guidelines
Is the Subject Area "Screening guidelines" applicable to this article?

Thanks for your feedback.
Tuberculosis diagnosis and management
Is the Subject Area "Tuberculosis diagnosis and management" applicable to this article?

Thanks for your feedback.